Post-COVID-19 condition patients' utilisation of healthcare resources after implementation of an integrated care unit

Background: The economic effects of post-COVID-19 condition (PCC) remain uncertain despite clearer clinical factors, posing challenges for healthcare professionals. This article investigates the demographic and clinical characteristics of PCC patients and compares their healthcare resource utilizati...

Descripción completa

Detalles Bibliográficos
Autores: Vicente-Gómez, José Ángel, Muniategui Climente, Martín, Loste, Cora, Barreales, Saúl, Ricou Ríos, Laura, Paredes, Roger, Mateu, Lourdes, López Seguí, Francesc, 1991-
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/72175
Acceso en línea:https://hdl.handle.net/10230/72175
http://dx.doi.org/10.1186/s12962-025-00667-z
http://hdl.handle.net/10230/72175
Access Level:acceso abierto
Palabra clave:COVID-19
Economic evaluation
Healthcare utilisation
Post-COVID-19 condition
Long COVID
Descripción
Sumario:Background: The economic effects of post-COVID-19 condition (PCC) remain uncertain despite clearer clinical factors, posing challenges for healthcare professionals. This article investigates the demographic and clinical characteristics of PCC patients and compares their healthcare resource utilization in comparison to a patient cohort representative of the population. Methods: A retrospective and cohort-comparative observational study was conducted, comparing PCC population before and after diagnosis with a control group. Demographic and clinical variables were analysed to describe the population. Economic analysis was performed to evaluate the resource costs in procedures and primary, secondary and emergency care. Results: PCC patients (N=341) were older with higher cardiovascular risk factors compared to controls (N=49,078). There were differences in the socio-economic distribution between male and female in the PCC patients. Hypertension and diabetes mellitus type 2 were the most common chronic diseases observed among the case patients. PCC patients were four times as costly as control patients, with increased utilisation of healthcare resources. However, post-diagnosis PCC patients showed a reduction in costs, primarily driven by decreased primary care visits and hospitalisations. Conclusions: Coordinated care for PCC patients leads to cost reductions and improved resource utilisation. Further research should investigate long-term health outcomes and establish causal relationships between COVID-19 sequelae and healthcare resource utilisation.